Cargando…

Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma

Detalles Bibliográficos
Autores principales:	Valentini, Davide, Rao, Martin, Meng, Qingda, von Landenberg, Anna, Bartek, Jiri, Sinclair, Georges, Paraschoudi, Georgia, Jäger, Elke, Harvey-Peredo, Inti, Dodoo, Ernest, Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298404/ https://www.ncbi.nlm.nih.gov/pubmed/30613370 http://dx.doi.org/10.18632/oncotarget.26447

Ejemplares similares

Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
por: Valentini, Davide, et al.
Publicado: (2018)

Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
por: Meng, Qingda, et al.
Publicado: (2018)

Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
por: Zhenjiang, Liu, et al.
Publicado: (2017)

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
por: Zhenjiang, Liu, et al.
Publicado: (2018)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
por: Liu, Zhenjiang, et al.
Publicado: (2018)

Rapid expansion of TILs from patients with glioma and recognition of autologous tumor
por: Zhenjiang, Liu, et al.
Publicado: (2014)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
por: Arnaud, Marion, et al.
Publicado: (2023)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
por: de Sousa, Eric, et al.
Publicado: (2021)

Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells
por: Dodoo, Ernest, et al.
Publicado: (2014)

KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
por: Meng, Qingda, et al.
Publicado: (2018)

Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine
por: Lérias, Joana R., et al.
Publicado: (2019)

A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer
por: Rangelova, Elena B, et al.
Publicado: (2014)

Adaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis
por: Sinclair, Georges, et al.
Publicado: (2016)

The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis
por: Sinclair, Georges, et al.
Publicado: (2018)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases
por: Sinclair, Georges, et al.
Publicado: (2019)

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
por: Hansen, Ulla Kring, et al.
Publicado: (2020)

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
por: Liu, Zhenjiang, et al.
Publicado: (2015)

Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses
por: Meng, Qingda, et al.
Publicado: (2018)

Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)
por: Nguyen, Linh T., et al.
Publicado: (2010)

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
por: Poch, Michael, et al.
Publicado: (2018)

Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies
por: Lérias, Joana R., et al.
Publicado: (2020)

The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017)

Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)

Salvage gamma knife radiosurgery in the management of dysembryoplastic neuroepithelial tumors: Long-term outcome in a single-institution case series
por: Sinclair, Georges, et al.
Publicado: (2017)

Higher Human Cytomegalovirus (HCMV) Specific IgG Antibody Levels in Plasma Samples from Patients with Metastatic Brain Tumors Are Associated with Longer Survival
por: Peredo-Harvey, Inti, et al.
Publicado: (2023)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
por: Hall, MacLean, et al.
Publicado: (2016)

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
por: Jiménez-Reinoso, Anaïs, et al.
Publicado: (2021)

Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
por: Fanale, Daniele, et al.
Publicado: (2022)

T-Cell Therapy: Options for Infectious Diseases
por: Parida, Shreemanta K., et al.
Publicado: (2015)

Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
por: Lérias, Joana R., et al.
Publicado: (2020)

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
por: Rao, Martin, et al.
Publicado: (2015)

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
por: Wickström, Stina L., et al.
Publicado: (2019)

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
por: Kos, Zuzana, et al.
Publicado: (2020)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022)

Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?
por: Ling, Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_khkdgvbpahh5t0ccs25kbke9nr